The findings of the present umbrella review suggest that vitamin D supplementation could decrease levels of FBS, insulin, HbA1C, and serum TG in prediabetic patients but fail to reduce HOMA-IR, 2 h-PG, HOMA-B, BMI, and diabetes risk in these patients. The gene discussed is INS; the disease is diabetes mellitus.